Royal Bank of Canada’s Arbutus Biopharma ABUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$825K Buy
267,187
+204,942
+329% +$633K ﹤0.01% 3751
2025
Q1
$218K Buy
62,245
+28,249
+83% +$98.9K ﹤0.01% 4293
2024
Q4
$111K Buy
33,996
+17,621
+108% +$57.5K ﹤0.01% 4813
2024
Q3
$63K Sell
16,375
-60,413
-79% -$232K ﹤0.01% 5127
2024
Q2
$237K Buy
76,788
+3,642
+5% +$11.2K ﹤0.01% 4250
2024
Q1
$188K Sell
73,146
-34,073
-32% -$87.6K ﹤0.01% 4309
2023
Q4
$268K Sell
107,219
-8,955
-8% -$22.4K ﹤0.01% 4324
2023
Q3
$236K Buy
116,174
+106,409
+1,090% +$216K ﹤0.01% 4177
2023
Q2
$22K Sell
9,765
-82,014
-89% -$185K ﹤0.01% 5697
2023
Q1
$277K Sell
91,779
-2,064
-2% -$6.23K ﹤0.01% 3999
2022
Q4
$218K Buy
93,843
+1,302
+1% +$3.03K ﹤0.01% 4344
2022
Q3
$177K Sell
92,541
-30,426
-25% -$58.2K ﹤0.01% 4396
2022
Q2
$334K Sell
122,967
-7,208
-6% -$19.6K ﹤0.01% 3963
2022
Q1
$388K Sell
130,175
-17,915
-12% -$53.4K ﹤0.01% 4026
2021
Q4
$576K Buy
148,090
+3,653
+3% +$14.2K ﹤0.01% 3847
2021
Q3
$620K Buy
144,437
+85,542
+145% +$367K ﹤0.01% 3707
2021
Q2
$179K Buy
58,895
+58,317
+10,089% +$177K ﹤0.01% 4694
2021
Q1
$2K Sell
578
-14,798
-96% -$51.2K ﹤0.01% 6709
2020
Q4
$55K Buy
15,376
+1,497
+11% +$5.36K ﹤0.01% 5071
2020
Q3
$43K Buy
13,879
+5,610
+68% +$17.4K ﹤0.01% 4922
2020
Q2
$15K Buy
8,269
+5,856
+243% +$10.6K ﹤0.01% 5207
2020
Q1
$3K Buy
2,413
+1,130
+88% +$1.41K ﹤0.01% 5660
2019
Q4
$3K Sell
1,283
-5,969
-82% -$14K ﹤0.01% 5856
2019
Q3
$11K Buy
7,252
+642
+10% +$974 ﹤0.01% 5114
2019
Q2
$14K Buy
6,610
+39
+0.6% +$83 ﹤0.01% 5071
2019
Q1
$23K Sell
6,571
-202
-3% -$707 ﹤0.01% 4835
2018
Q4
$26K Sell
6,773
-4,283
-39% -$16.4K ﹤0.01% 4734
2018
Q3
$104K Buy
11,056
+2,983
+37% +$28.1K ﹤0.01% 4241
2018
Q2
$60K Sell
8,073
-6,926
-46% -$51.5K ﹤0.01% 4493
2018
Q1
$75K Buy
14,999
+4,104
+38% +$20.5K ﹤0.01% 4249
2017
Q4
$55K Buy
10,895
+540
+5% +$2.73K ﹤0.01% 4388
2017
Q3
$64K Sell
10,355
-3,500
-25% -$21.6K ﹤0.01% 4543
2017
Q2
$50K Sell
13,855
-125
-0.9% -$451 ﹤0.01% 4387
2017
Q1
$46K Sell
13,980
-7,250
-34% -$23.9K ﹤0.01% 4530
2016
Q4
$52K Buy
21,230
+8,280
+64% +$20.3K ﹤0.01% 4482
2016
Q3
$45K Sell
12,950
-240
-2% -$834 ﹤0.01% 4461
2016
Q2
$46K Sell
13,190
-400
-3% -$1.4K ﹤0.01% 4477
2016
Q1
$56K Sell
13,590
-1,860
-12% -$7.66K ﹤0.01% 4386
2015
Q4
$68K Sell
15,450
-54,850
-78% -$241K ﹤0.01% 4440
2015
Q3
$428K Buy
70,300
+2,240
+3% +$13.6K ﹤0.01% 3133
2015
Q2
$808K Buy
68,060
+35,133
+107% +$417K ﹤0.01% 2691
2015
Q1
$575K Buy
32,927
+3,802
+13% +$66.4K ﹤0.01% 2951
2014
Q4
$442K Buy
29,125
+13,075
+81% +$198K ﹤0.01% 3171
2014
Q3
$340K Sell
16,050
-17,540
-52% -$372K ﹤0.01% 3299
2014
Q2
$439K Buy
33,590
+13,560
+68% +$177K ﹤0.01% 3079
2014
Q1
$430K Buy
20,030
+1,900
+10% +$40.8K ﹤0.01% 3005
2013
Q4
$144K Hold
18,130
﹤0.01% 3768
2013
Q3
$127K Sell
18,130
-780
-4% -$5.46K ﹤0.01% 3800
2013
Q2
$88K Buy
+18,910
New +$88K ﹤0.01% 3805